Avatar for Freenome

Biotech company specializing in early cancer diagnoses

Biotech company specializing in early cancer diagnoses

Freenome is on a mission to empower everyone with the tools they need to detect, treat, and ultimately prevent diseases. If you crave challenges, understudied problems, and the chance to see your work impact the millions of lives touched by cancer, there’s no better place to be. We are committed to our core values of empathy, integrity, and trust enable us to push through challenges, learn from mistakes, and support one another to reach our fullest potential. By applying advanced ML techniques to recent breakthroughs in genomic science, Freenome is developing simple blood tests to detect early-stage cancer and make treatments more effective. The company has raised $238M from investors such as RA Capital, Polaris Partners, Perceptive Advisors, a16z, funds/accounts advised by T. Rowe Price Associates, Inc., GV (fka Google Ventures), Roche Venture Fund, Kaiser Permanente Ventures, American Cancer Society’s BrightEdge Ventures, Data Collective Venture Capital, & Verily Life Sciences.

Senior Infrastructure Engineer

Senior Research Scientist - Proteomics

Senior Software Engineer - Backend

Senior Software Engineer - Infrastructure

Senior Software Engineer - Frontend

Senior Research Scientist - Genomics

Co-Founder, COO at @Freenome
Founder and CEO @Freenome • Worked at @Apple, @Glyde • Studied at @Cornell University
Total raised

$256.3M

Funded over

5 rounds

Latest round

Series B (Jul 2019)